Metformin monotherapy in lean women with polycystic ovary syndrome.

  title={Metformin monotherapy in lean women with polycystic ovary syndrome.},
  author={Aruna Kumari and Afrozul Haq and Ravichandra Jayasundaram and Laila Osama Abdel-Wareth and S A Al Haija and Michael L Alvares},
  journal={Reproductive biomedicine online},
  volume={10 1},
This study was carried out to compare ovulation and pregnancy rates in response to metformin therapy in lean and obese women with polycystic ovary syndrome (PCOS). A total of 34 (17 lean and 17 obese) women with PCOS were treated with 500 mg metformin 3 times daily for 12 weeks. In the lean and obese groups, the mean body mass index was 24 and 36, and the mean fasting insulin concentrations were 12 and 21 mIU/l respectively. There was no difference between the two groups as regarding age, DHEA… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 14 extracted citations

The role of metformin in the treatment of polycystic ovary syndrome (PCOS).

Chang Gung medical journal • 2006
View 10 Excerpts
Highly Influenced

The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology • 2009

Similar Papers

Loading similar papers…